These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort. Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780 [TBL] [Abstract][Full Text] [Related]
5. Serum soluble tumour necrosis factor receptor-2 (sTNFR2) as a biomarker of kidney tissue damage and long-term renal outcome in lupus nephritis. Parodis I; Ding H; Zickert A; Arnaud L; Larsson A; Svenungsson E; Mohan C; Gunnarsson I Scand J Rheumatol; 2017 Jul; 46(4):263-272. PubMed ID: 27973968 [TBL] [Abstract][Full Text] [Related]
6. Renal vascular lesions in lupus nephritis. Descombes E; Droz D; Drouet L; Grünfeld JP; Lesavre P Medicine (Baltimore); 1997 Sep; 76(5):355-68. PubMed ID: 9352738 [TBL] [Abstract][Full Text] [Related]
7. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study. Navarro D; Ferreira AC; Viana H; Carvalho F; Nolasco F Acta Med Port; 2019 Oct; 32(10):635-640. PubMed ID: 31625875 [TBL] [Abstract][Full Text] [Related]
8. The severity of glomerular endothelial cell injury is associated with infiltrating macrophage heterogeneity in endocapillary proliferative glomerulonephritis. Arai M; Mii A; Kashiwagi T; Shimizu A; Sakai Y Sci Rep; 2021 Jun; 11(1):13339. PubMed ID: 34172770 [TBL] [Abstract][Full Text] [Related]
9. Relation of peritubular capillary features to class of lupus nephritis. Anutrakulchai S; Titipungul T; Pattay T; Mesung P; Puapairoj A; Sirivongs D; Pongsakul C; Futrakul P; Thinkhamrop B; Johnson RJ BMC Nephrol; 2016 Nov; 17(1):169. PubMed ID: 27829387 [TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 9 and vascular endothelial growth factor levels in human kidneys from lupus nephritis patients. Frieri M; Samih MA; Dzhindzhikhashvili M; Liu H; Balsam L; Rubinstein S J Nephrol; 2012; 25(6):1041-6. PubMed ID: 22344539 [TBL] [Abstract][Full Text] [Related]
11. Membrane attack complex (mac) deposition in lupus nephritis is associated with hypertension and poor clinical response to treatment. Wang S; Wu M; Chiriboga L; Zeck B; Belmont HM Semin Arthritis Rheum; 2018 Oct; 48(2):256-262. PubMed ID: 29395256 [TBL] [Abstract][Full Text] [Related]
12. What is the value of repeat kidney biopsies in patients with lupus nephritis? Morales E; Trujillo H; Bada T; Alonso M; Gutiérrez E; Rodríguez E; Gutiérrez E; Galindo M; Praga M Lupus; 2021 Jan; 30(1):25-34. PubMed ID: 33081588 [TBL] [Abstract][Full Text] [Related]
13. Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study. Broder A; Mowrey WB; Khan HN; Jovanovic B; Londono-Jimenez A; Izmirly P; Putterman C Semin Arthritis Rheum; 2018 Feb; 47(4):545-551. PubMed ID: 28803673 [TBL] [Abstract][Full Text] [Related]
15. Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial. Stoenoiu MS; Aydin S; Tektonidou M; Ravelingien I; le Guern V; Fiehn C; Remy P; Delahousse M; Petera P; Quémeneur T; Vasconcelos C; D'Cruz D; Gilboe IM; Jadoul M; Karras A; Depresseux G; Guillevin L; Cervera R; Cosyns JP; Houssiau FA; Nephrol Dial Transplant; 2012 May; 27(5):1924-30. PubMed ID: 22110048 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death. Arriens C; Chen S; Karp DR; Saxena R; Sambandam K; Chakravarty E; James JA; Merrill JT Clin Immunol; 2017 Dec; 185():3-9. PubMed ID: 27923701 [TBL] [Abstract][Full Text] [Related]
17. The prognostic values of caveolin-1 immunoreactivity in peritubular capillaries in patients with kidney transplantation. Nakada Y; Yamamoto I; Horita S; Kobayashi A; Mafune A; Katsumata H; Yamakawa T; Katsuma A; Kawabe M; Tanno Y; Ohkido I; Tsuboi N; Yamamoto H; Okumi M; Ishida H; Yokoo T; Tanabe K; Clin Transplant; 2016 Nov; 30(11):1417-1424. PubMed ID: 27543925 [TBL] [Abstract][Full Text] [Related]
18. A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from China. Tao J; Wang H; Yu XJ; Tan Y; Yu F; Wang SX; Haas M; Glassock RJ; Zhao MH Am J Nephrol; 2020; 51(6):483-492. PubMed ID: 32320985 [TBL] [Abstract][Full Text] [Related]
19. Beta2-glycoprotein I Expression in Lupus Nephritis Patients with Antiphospholipid-associated Nephropathy. Gao R; Yu W; Wen Y; Li H J Rheumatol; 2016 Nov; 43(11):2026-2032. PubMed ID: 27633824 [TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis. Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]